Discover
PHVS
Pharvaris N.V.
36.37
2 x 26.64
2 x 46.40
bid
ask
-
1.63
4.29%
2 @ 07:30 PM
36.01 -0.36 (0.99%)
| Ytd | 31.06% | |
| 1y | 48.21% |
36.08
day range
38.20
20.96
52 week range
38.86
| Open | 38.20 | Prev Close | 38.00 | Low | 36.08 | High | 38.20 | Mkt Cap | 2.55B |
| Vol | 580.26K | Avg Vol | 724.28K | EPS | -3.00 | P/E | N/A | Forward P/E | -11.63 |
| Beta | -2.32 | Short Ratio | 3.36 | Inst. Own | 93.14% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 35.36 | 200-d Avg | 30.03 | 1yr Est | 58.38 |
| Income Statement | |||
| Operating Expenses | 50.79M | ||
| Research and Development Expense | 35.00M | ||
| Selling, General and Administrative Expense | 15.79M | ||
| Operating Income | -50.79M | ||
| Interest Expense | -3.55M | ||
| Income Tax Expense | 602.20K | ||
| Net Income | -47.84M | ||
| Net Income Common Stock | -47.84M | ||
| Net Income Common Stock (USD) | -54.37M | ||
| Consolidated Income | -47.84M | ||
| Earnings per Basic Share | -0.70 | ||
| Earnings per Basic Share (USD) | -0.79 | ||
| Earnings per Diluted Share | -0.70 | ||
| Earning Before Interest & Taxes (EBIT) | -50.79M | ||
| Earning Before Interest & Taxes (USD) | -57.71M | ||
| Weighted Average Shares | 65.40M | ||
| Balance Sheet | |||
| Cash and Equivalents | 318.28M | ||
| Cash and Equivalents (USD) | 361.68M | ||
| Trade and Non-Trade Receivables | 1.07M | ||
| Current Assets | 322.68M | ||
| Property, Plant & Equipment Net | 1.21M | ||
| Total Assets | 328.67M | ||
| Debt Current | 192.40K | ||
| Total Debt | 673.73K | ||
| Debt Non-Current | 481.33K | ||
| Total Liabilities | 27.86M | ||
| Accumulated Retained Earnings (Deficit) | -668.58M | ||
| Accumulated Other Comprehensive Income | 468.77K | ||
| Shareholders Equity | 300.81M | ||
| Shareholders Equity (USD) | 341.83M | ||
| Assets Non-Current | 5.99M | ||
| Total Debt (USD) | 765.60K | ||
| Trade and Non-Trade Payables | 2.79M | ||
| Tax Assets | 4.78M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 179.30K | ||
| Net Cash Flow from Financing | 105.87M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 68.05M | ||
| Capital Expenditure | -26.91K | ||
| Issuance (Purchase) of Equity Shares | 113.13M | ||
| Issuance (Repayment) of Debt Securities | -62.04K | ||
| Net Cash Flow from Investing | -26.91K | ||
| Net Cash Flow from Operations | -37.80M | ||
| Effect of Exchange Rate Changes on Cash | 3.28M | ||
| Share Based Compensation | 6.63M | ||